951745-01-0 Usage
Description
N-Boc-4-Methylpiperidinecarbothioamide is a chemical compound that belongs to the class of piperidines. It is commonly used as a reagent in organic synthesis and pharmaceutical research. Known for its potential applications in the production of pharmaceutical drugs and agrochemicals, this versatile compound is also used as a building block in the synthesis of various bioactive compounds. It is important to handle this chemical with care and adhere to proper safety protocols when working with it in a laboratory setting.
Uses
Used in Pharmaceutical Research:
N-Boc-4-Methylpiperidinecarbothioamide is used as a reagent for the synthesis of pharmaceutical drugs. Its versatile nature in chemical reactions allows for the creation of a wide range of bioactive compounds, making it a valuable asset in drug development.
Used in Agrochemical Production:
N-Boc-4-Methylpiperidinecarbothioamide is also utilized in the production of agrochemicals. Its role as a building block in the synthesis of various compounds contributes to the development of effective agricultural products.
Used in Organic Synthesis:
As a reagent in organic synthesis, N-Boc-4-Methylpiperidinecarbothioamide is employed for the creation of a diverse array of chemical compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis process.
Check Digit Verification of cas no
The CAS Registry Mumber 951745-01-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,7,4 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 951745-01:
(8*9)+(7*5)+(6*1)+(5*7)+(4*4)+(3*5)+(2*0)+(1*1)=180
180 % 10 = 0
So 951745-01-0 is a valid CAS Registry Number.
951745-01-0Relevant articles and documents
OXYMETHYLENE ARYL COMPOUNDS FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES OR GASTROINTESTINAL CONDITIONS
-
, (2018/03/28)
Use of oxymethylene aryl GPRl 19 agonists, and optionally DPP IV inhibitors and optionally metformin, for the treatment of inflammatory gastrointestinal diseases or gastrointestinal conditions involving malabsorption of nutrients and/or fluids are provide
HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
-
Page/Page column 97, (2008/12/07)
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.